10-QPeriod: Q2 FY2022

AMETEK INC/ Quarterly Report for Q2 Ended Jun 30, 2022

Filed August 2, 2022For Securities:AME

Summary

AMETEK, Inc. reported strong financial results for the second quarter and the first six months of 2022, showcasing record sales and operating income. For the three months ended June 30, 2022, net sales increased by 9.2% to $1.51 billion, with diluted EPS rising 22.0% to $1.22. The six-month period saw net sales grow 14.3% to $2.97 billion and diluted EPS increase 23.2% to $2.39. This growth was driven by organic sales increases across both the Electronic Instruments (EIG) and Electromechanical (EMG) segments, supported by the company's Operational Excellence initiatives. Despite ongoing global economic challenges, including inflation and supply chain constraints, AMETEK demonstrated resilience by effectively managing costs and implementing pricing strategies. The company's financial position remains robust, with a strong backlog of $3.10 billion as of June 30, 2022, up 13.7% from December 31, 2021, indicating sustained demand. AMETEK also continued its capital allocation strategy through increased dividends and significant share repurchases, underscoring confidence in its financial health and future prospects. The company has updated its revolving credit facility, increasing its capacity to $2.3 billion, providing ample liquidity for operational needs and strategic growth.

Financial Highlights

52 data points
Beta

Revenue

$1.51B

34.8% Gross Margin

Net Income

$282.37M

18.6% Net Margin

EPS (Diluted)

$1.22

Total Assets

$11.98B

Cash & Equivalents

$348.65M

Free Cash Flow

$209.75M

Financial Statements
Beta
Revenue$1.51B
Cost of Revenue$988.17M
Gross Profit$526.38M
SG&A Expenses$161.53M
Operating Expenses$1.15B
Operating Income$364.84M
Interest Expense$20.35M
Net Income$282.37M
EPS (Basic)$1.23
EPS (Diluted)$1.22
Shares Outstanding (Basic)230.10M
Shares Outstanding (Diluted)231.25M

Key Highlights

  • 1Record net sales of $1.51 billion for Q2 2022, up 9.2% year-over-year, driven by organic growth across both EIG and EMG segments.
  • 2Diluted EPS of $1.22 for Q2 2022, a 22.0% increase compared to $1.00 in Q2 2021.
  • 3Six-month net sales reached $2.97 billion, up 14.3% year-over-year, with diluted EPS of $2.39.
  • 4Record backlog of $3.10 billion as of June 30, 2022, representing a 13.7% increase from year-end 2021, indicating strong future revenue potential.
  • 5Segment operating margins improved to 25.7% in Q2 2022 from 24.5% in Q2 2021, reflecting effective cost management and operational efficiencies.
  • 6Increased revolving credit facility capacity to $2.3 billion, enhancing financial flexibility and liquidity.
  • 7Continued return of capital to shareholders with a 10% increase in quarterly dividend to $0.22 per share and significant share repurchases totaling $331.4 million in the first half of 2022.

Frequently Asked Questions

The increase in net sales for the second quarter of 2022 was primarily driven by a 12% increase in organic sales across both the Electronic Instruments Group (EIG) and Electromechanical Group (EMG) segments. This organic growth was supplemented by a 1% increase from acquisitions, though partially offset by an unfavorable 3% effect of foreign currency translation.

AMETEK implemented pricing actions to mitigate the impact of material and transportation cost inflation. To address supply chain pressures, including component shortages and strained transportation capacity, the company took actions to build inventory and sought alternative sources of supply to support sales and backlog growth.

AMETEK reported a record backlog of $3,104.4 million as of June 30, 2022, an increase of 13.7% from December 31, 2021. This significant increase in backlog indicates robust customer demand and provides a strong foundation for future revenue generation.

AMETEK is actively returning capital to shareholders through dividends and share repurchases. The company increased its quarterly cash dividend by 10% to $0.22 per common share. Additionally, AMETEK repurchased $331.4 million of its common stock in the first six months of 2022 under a new $1 billion share repurchase authorization.